patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re-posting Craig's Post this morning

Re-posting Craig's Post this morning

posted on May 14, 2007 07:53AM
Re: PLRS Price/Volume action/comments


 

Dear Tonbo, 7th Angel and Ferman,

Pluristem's listing on the DAX (Frankfurt Exchange) is consistent with the Company's business strategy.  Zami Aberman has one of the best business strategies I have seen in years and his execution is superb. I believe this will prove to be a smart decision once the other business developments are realized.

I see no evidence of aggressive shorting, let alone naked shorts.  For April, there was just over 331,000 shares short, which is consistent with previous months. If you want to monitor the short activity, I suggest you go to http://www.otcbb.com/asp/OTCE_Short_Interest.asp and enter PLRS.

Respectfully,

Craig

 

One7thhvn's: No shares were traded in Europe so far, Still waiting for their action

Share
New Message
Please login to post a reply